ArticlePharmaceutics2025

Physiologically Based Pharmacokinetic Models for Infliximab, Ipilimumab, and Nivolumab Developed with GastroPlus to Predict Hepatic Concentrations.

Celeste Vallejo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.